Brief: Maia Biotechnology Inc - Decreases Maximum Aggregate Offering Price To $11.2 Million - SEC Filing
26/03/2025 21:16
March 26 (Reuters) - Maia Biotechnology Inc MAIA.A: MAIA BIOTECHNOLOGY INC - DECREASES MAXIMUM AGGREGATE OFFERING PRICE TO $11.2 MILLION - SEC FILING Source text: [ID:n0001641172-25-000788] Further company coverage: MAIA.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maia Biotechnology
See all newsBrief: Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr In 3l Nsclc
Brief: Maia Biotechnology - To Terminate At The Market Offering Agreement Effective May 23, 2026 - SEC Filing
Brief: Maia Biotechnology Reports Overall Survival Exceeding Two Years For Eight Patients In Ongoing Phase 2 Clinical Trial In Non-Small Cell Lung Cancer
Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
MAIA Biotechnology plunges after $30 million share sale